Heat Diffusion Imaging
The new functional imaging modality developed by HT BioImaging is based on heat diffusion. After a focused heatwave is sent to the tissue, the unique algorithm views biological tissue as a filter and measures its heat diffusion response by signal analysis, computer vision, and AI, giving each 0.1mm spot a probability of being cancerous or not. It thus can be used to distinguish between cancer and other pathologies such as pre-cancer, benign growths, or necrosis at very early stages.
HDI scanner is an In-human oncology tool to detect cancer at the point of care and operating rooms. Our first medical indication is a 510k De-Novo Oral cancer application. Future medical indications are Cervical, Skin, prostate, colon, and an intraoperative tool for navigation and margin detection and mapping at the OR. HTOScan has been tested on 150 patients in a clinical trial (USA & Israel) showing above 90% accuracy in detecting cancer.
Cancer is a leading cause of death in dogs and cats worldwide.
10 dogs a week arrive to the veterinarian with a lump, a dermal or subcutaneous mass, that may be cancer.
14.5 million masses are detected every year, In the US alone.
40% of them are not even being diagnosed.
The common diagnostic procedures are invasive, expensive, and time consuming.
HT Vista is the first non-invasive medical device that allows veterinarians to rule out cancer of subcutaneous and dermal masses at the clinic in a fast and affordable way.
HT Vista serves as a first line diagnostic test with a goal to detect and classify a mass as benign or malignant by getting “on the spot” results in the vet clinic with a negative predictive value of over 95%.
HT Vista is keeping the lesion classification and analysis phase in-clinic, under the control of the vet, without the need to rely on outsource lab diagnostics. This creates a new revenue stream for the vet clinic while the test cost is less than 25% of the current lab cost and thus, rising the number of the tests taken to save lives.
The HT Vista is a game-changer that empowers veterinarians to classify and detect cancer earlier
HT Vsiat has been tested on over 400 dogs in clinical trials (USA & Israel).